NatureWise Biotech & Medicals Corporation (TPEX:4732)

TPEX:4732 Revenue

NatureWise Biotech & Medicals had revenue of 90.00M TWD in the half year ending December 31, 2025, a decrease of -4.03%. This brings the company's revenue in the last twelve months to 174.62M, down -3.15% year-over-year. In the year 2025, NatureWise Biotech & Medicals had annual revenue of 176.77M, down -21.20%.

• Revenue (ttm): 174.62M
• Revenue Growth: -3.15%
• P/S Ratio: 4.57
• Revenue / Employee: 5.46M
• Employees: 32
• Market Cap: 798.52M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	176.77M	-47.56M	-21.20%
Dec 31, 2024	224.32M	64.18M	40.08%
Dec 31, 2023	160.14M	-68.45M	-29.94%
Dec 31, 2022	228.59M	-21.21M	-8.49%
Dec 31, 2021	249.80M	-57.12M	-18.61%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 26, 2026

Data Sources Report a data error